Anticholinergics and antacid tablets versus cimetidine in the treatment of active duodenal ulcers

J. C. Meeroff, M. Meeroff, A. Serchio

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

A 4-week comparative open prospective randomized trial of cimetidine versus a combination of a low dose of antacids plus a low dose of an anticholinergic antimuscarinic agent was conducted in 50 outpatients with endoscopically proven active duodenal ulcers. Ulcer healing occurred in 17 of 25 patients receiving cimetidine (68%) and in 19 of 25 patients receiving the combination of antacids plus anticholinergics (76%). Patients with unhealed ulcers after the 4-week trial period were crossed-over to the other treatment and ulcers healed in 5 of 8 patients switched to the combination of antacids plus anticholinergics and in 3 of 6 patients switched to cimetidine after 3 weeks of treatment. Minor side effects were reported in 8 patients receiving cimetidine and in 7 receiving the combination of antacids plus anticholinergics. Eight of 14 patients (57%) with unhealed ulcers became asymptomatic during the last week of the trial, which indicates that freedom from ulcer pain is a poor predictor of healing. It is concluded that the treatment based on the combination of a low dose of antacids and a low dose of anticholinergic antimuscarinic agents is as effective as cimetidine for enhancing healing of acute duodenal ulcers.

Original languageEnglish
Pages (from-to)866-873
Number of pages8
JournalCurrent Therapeutic Research - Clinical and Experimental
Volume29
Issue number6 I
StatePublished - Jan 1 1981

Fingerprint

Antacids
Cimetidine
Cholinergic Antagonists
Duodenal Ulcer
Tablets
Ulcer
Muscarinic Antagonists
Therapeutics
Outpatients
Pain

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Anticholinergics and antacid tablets versus cimetidine in the treatment of active duodenal ulcers. / Meeroff, J. C.; Meeroff, M.; Serchio, A.

In: Current Therapeutic Research - Clinical and Experimental, Vol. 29, No. 6 I, 01.01.1981, p. 866-873.

Research output: Contribution to journalArticle

@article{edd95a972ea149e082e842f4d8155b67,
title = "Anticholinergics and antacid tablets versus cimetidine in the treatment of active duodenal ulcers",
abstract = "A 4-week comparative open prospective randomized trial of cimetidine versus a combination of a low dose of antacids plus a low dose of an anticholinergic antimuscarinic agent was conducted in 50 outpatients with endoscopically proven active duodenal ulcers. Ulcer healing occurred in 17 of 25 patients receiving cimetidine (68{\%}) and in 19 of 25 patients receiving the combination of antacids plus anticholinergics (76{\%}). Patients with unhealed ulcers after the 4-week trial period were crossed-over to the other treatment and ulcers healed in 5 of 8 patients switched to the combination of antacids plus anticholinergics and in 3 of 6 patients switched to cimetidine after 3 weeks of treatment. Minor side effects were reported in 8 patients receiving cimetidine and in 7 receiving the combination of antacids plus anticholinergics. Eight of 14 patients (57{\%}) with unhealed ulcers became asymptomatic during the last week of the trial, which indicates that freedom from ulcer pain is a poor predictor of healing. It is concluded that the treatment based on the combination of a low dose of antacids and a low dose of anticholinergic antimuscarinic agents is as effective as cimetidine for enhancing healing of acute duodenal ulcers.",
author = "Meeroff, {J. C.} and M. Meeroff and A. Serchio",
year = "1981",
month = "1",
day = "1",
language = "English",
volume = "29",
pages = "866--873",
journal = "Current Therapeutic Research",
issn = "0011-393X",
publisher = "Excerpta Medica",
number = "6 I",

}

TY - JOUR

T1 - Anticholinergics and antacid tablets versus cimetidine in the treatment of active duodenal ulcers

AU - Meeroff, J. C.

AU - Meeroff, M.

AU - Serchio, A.

PY - 1981/1/1

Y1 - 1981/1/1

N2 - A 4-week comparative open prospective randomized trial of cimetidine versus a combination of a low dose of antacids plus a low dose of an anticholinergic antimuscarinic agent was conducted in 50 outpatients with endoscopically proven active duodenal ulcers. Ulcer healing occurred in 17 of 25 patients receiving cimetidine (68%) and in 19 of 25 patients receiving the combination of antacids plus anticholinergics (76%). Patients with unhealed ulcers after the 4-week trial period were crossed-over to the other treatment and ulcers healed in 5 of 8 patients switched to the combination of antacids plus anticholinergics and in 3 of 6 patients switched to cimetidine after 3 weeks of treatment. Minor side effects were reported in 8 patients receiving cimetidine and in 7 receiving the combination of antacids plus anticholinergics. Eight of 14 patients (57%) with unhealed ulcers became asymptomatic during the last week of the trial, which indicates that freedom from ulcer pain is a poor predictor of healing. It is concluded that the treatment based on the combination of a low dose of antacids and a low dose of anticholinergic antimuscarinic agents is as effective as cimetidine for enhancing healing of acute duodenal ulcers.

AB - A 4-week comparative open prospective randomized trial of cimetidine versus a combination of a low dose of antacids plus a low dose of an anticholinergic antimuscarinic agent was conducted in 50 outpatients with endoscopically proven active duodenal ulcers. Ulcer healing occurred in 17 of 25 patients receiving cimetidine (68%) and in 19 of 25 patients receiving the combination of antacids plus anticholinergics (76%). Patients with unhealed ulcers after the 4-week trial period were crossed-over to the other treatment and ulcers healed in 5 of 8 patients switched to the combination of antacids plus anticholinergics and in 3 of 6 patients switched to cimetidine after 3 weeks of treatment. Minor side effects were reported in 8 patients receiving cimetidine and in 7 receiving the combination of antacids plus anticholinergics. Eight of 14 patients (57%) with unhealed ulcers became asymptomatic during the last week of the trial, which indicates that freedom from ulcer pain is a poor predictor of healing. It is concluded that the treatment based on the combination of a low dose of antacids and a low dose of anticholinergic antimuscarinic agents is as effective as cimetidine for enhancing healing of acute duodenal ulcers.

UR - http://www.scopus.com/inward/record.url?scp=0019413609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019413609&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0019413609

VL - 29

SP - 866

EP - 873

JO - Current Therapeutic Research

JF - Current Therapeutic Research

SN - 0011-393X

IS - 6 I

ER -